Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.475 HKD | +6.74% | +14.29% | -22.58% |
12/04 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
08/04 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.58% | 7.39Cr | |
+7.52% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.23TCr | |
-4.18% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+37.41% | 1.25TCr | |
-23.95% | 834.13Cr |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals Completes Submission of Application for Seasonal Flu Vaccine in Brazil